Skip to main content
SpringerLink
Log in

Aducanumab

Amyloid-related imaging abnormalities in the brain: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • VandeVrede L, et al. Symptomatic amyloid-related imaging abnormalities in an APOE epsilon4/epsilon4 patient treated with aducanumab. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring 12: No. 1, Jan 2020. Available from: URL: http://doi.org/10.1002/dad2.12101

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aducanumab. Reactions Weekly 1867, 23 (2021). https://doi.org/10.1007/s40278-021-00083-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00083-3

Search

Navigation